News & Events

FEATURED STORY

Featured, Press Release

Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing

In the News

March 4, 2024

Phagenesis Successfully Closes a $42M Series D Financing Round Led by EQT Life Sciences and Sectoral Asset Management

May 11, 2023

AU Health Is the First Acute Care Center in the U.S. to Offer Breakthrough Dysphagia Treatment

December 1, 2021

Rapid Swallow Improvement Following Pharyngeal Electrical Stimulation in a COVID-19 Patient With Long-Term Severe Neurogenic Dysphagia: A Case Report

Webinars

May 16, 2025

Advancing Dysphagia Management: An Introduction to PES

August 7, 2024

Pioneering Dysphagia Rehabilitation With Pharyngeal Electrical Stimulation

Stories

November 1, 2024

Phagenesis CEO Hoskins on Helping Stroke Survivors Recover; How Distalmotion Will Target ASCs

August 15, 2023

Arizona Chef Able to Swallow Again Thanks to New Therapy Used to Treat Stroke Patients at Banner – University Medical Center Phoenix

April 20, 2020

Pharyngeal Electrical Stimulation Helps Critically Ill COVID-19 Patients With Dysphagia Recover Safely: A Case Report Using the Phagenyx PES System

Events

We’re hitting the road to share the latest clinical evidence, patient outcomes, and real-world impact of Phagenyx at leading stroke, neurology, and rehabilitation conferences across the globe. Meet the Phagenesis team, see a live demo, or attend our speaking sessions.